Inventor · disambiguated record
Saul J. Priceman
Also filed as: PRICEMAN SAUL J
6 granted patents·8 pending applications·13 citations·filing 2016–2025
75Inventor score
Files withHOPE CITY14
Top patents by PatentIndex Score
14 records- 0193US11197919B2Chimeric antigen receptors targeting HER2HOPE CITY·Filed 2016·Granted Dec 14, 2021·11 cites·60 claims
- 0279US2025333471A1Chimeric Antigen Receptors Targeting HER2HOPE CITY·Filed 2024·Application pending·0 cites
- 0377US12129286B2Membrane-bound IL-12 for cellular immunotherapyHOPE CITY·Filed 2024·Granted Oct 29, 2024·0 cites·14 claims
- 0476US11466097B2Chimeric antigen receptors targeted to PSCAHOPE CITY·Filed 2016·Granted Oct 11, 2022·1 cites·13 claims
- 0575US12281152B2TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumorsHOPE CITY·Filed 2019·Granted Apr 22, 2025·1 cites·42 claims
- 0673US2025257110A1Membrane-bound il-12 for cellular immunotherapyHOPE CITY·Filed 2024·Application pending·0 cites
- 0769US12472233B2Administration of engineered T cells for treatment of cancers in the central nervous systemHOPE CITY·Filed 2020·Granted Nov 18, 2025·0 cites·16 claims
- 0868US2022265796A1Chimeric antigen receptors targeting her2HOPE CITY·Filed 2021·Application pending·0 cites
- 0966US2025381237A1Oncolytic virus expressing a car t cell target and uses thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 1065US2025146017A1Methods comprising oncolytic viruses expressing cd19t and bispecific t cell engagersHOPE CITY·Filed 2024·Application pending·0 cites
- 1161US12364724B2Oncolytic virus expressing a car T cell target and uses thereofHOPE CITY·Filed 2018·Granted Jul 22, 2025·0 cites·11 claims
- 1256US2025129139A1CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING gD AND ONCOLYTIC VIRUSES FOR CANCER THERAPY AND TREATMENT OF HSVHOPE CITY·Filed 2022·Application pending·0 cites
- 1354US2017224733A1Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous SystemHOPE CITY·Filed 2017·Application pending·0 cites
- 1446US2023065784A1Composition and method for reducing expression of checkpoint inhibitors in t cells expressing a car or ctlHOPE CITY·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Saul J. Priceman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →